Even in a small subgroup of patients with early stage pancreatic cancer (UICC II), MMP-7 and MMP-12 were good classifiers to distinguish between patients with pancreatic cancer and healthy donors. This evidence concerns the gene MMP12 and pancreatic neoplasm.